NEURACLE SCIENCE

Batch9MPKRMPKR02
Written By Morning Pitch

Neuracle Science is a clinical-stage biotech company focused on discovering and developing novel antibody therapeutics for the treatment of neurological disorders. Our lead antibody program is NS101, which provides a promising therapeutic option to treat multiple neurological diseases caused by synapse loss. We have completed a phase 1 trial for NS101 and expect to start a phase 2 trial in Korea in 2H of 2023.

URL: http://www.neuracles.com/

Location: Korea

Morning Pitch
Previous

Mirae Cell Bio
Next

LISCure Biosciences